Defining the structural basis for human leukocyte antigen reactivity in clinical transplantation
Abstract The current state-of-the-art technology employed to assess anti-human leukocyte antigen antibodies (Anti-HLA Natural Gas Conversion Kit Ab) for donor-recipient matching and patient risk stratification in renal transplantation is the single antigen bead (SAB) assay.However, there are limitations to the SAB assay as it is not quantitative an